feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouUnited StatesUnited States
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / Colorado Rushes Psychedelic Therapy Access

Colorado Rushes Psychedelic Therapy Access

6 Feb

•

Summary

  • Colorado lawmakers are expediting access to potential new psychedelic therapies.
  • A new bill aims to fast-track FDA-approved psychedelic drugs for use.
  • Combat veteran finds healing from PTSD with psychedelic treatment.
Colorado Rushes Psychedelic Therapy Access

Colorado is preparing for the potential FDA approval of the first prescription psychedelic therapy, with lawmakers actively working to ensure immediate access for residents. A bill passed in 2022 allowed for psilocybin prescription post-FDA and DEA clearance, but it was limited to that specific substance. To address this, lawmakers introduced SB26-031 to fast-track any Schedule I drug approved for pharmaceutical use, aligning state and federal drug schedules.

Combat veteran Luke Schartiger supports the bill, sharing his personal journey of overcoming PTSD, depression, and anxiety through psychedelic treatment after traditional methods failed. He emphasizes how this alternative healing method helped him process deep-seated trauma and find peace. State Sen. Dafna Michaelson Jenet, a sponsor, notes that clinical trials for PTSD, anxiety, and depression have shown promising results, with potential for one-dose medications to offer lifelong relief.

Under the proposed bill, any psychedelic drug cleared by the FDA and DEA would be regulated as a standard prescription in Colorado. Unlike psilocybin used in healing centers, pharmaceutical-grade psychedelics are expected to be synthetically produced with precise dosages. The bill has already passed its first committee unanimously, indicating strong legislative support for advancing these novel treatments.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
Colorado lawmakers are working to ensure immediate access for residents to psychedelic therapies that may be approved by the FDA, with a new bill aiming to fast-track Schedule I drugs.
Combat veterans like Luke Schartiger have found relief from PTSD, depression, and anxiety through psychedelic treatment when other methods failed.
Bill SB26-031 seeks to fast-track all Schedule I drugs approved for pharmaceutical use by the FDA and DEA, aligning state and federal drug schedules for quicker access.

Read more news on

Healthside-arrow
trending

Islamabad suicide blast kills 31

trending

Vaibhav Suryavanshi scores 175

trending

Ronaldo trains with Al Nassr

trending

MRF profit doubles

trending

VTU adopts Artificial Super Intelligence

trending

RajaSaab OTT release on JioHotstar

trending

T20 World Cup opening ceremony

trending

Thakur captains Mumbai in Quarterfinal

trending

Riyan Parag scores fifty

You may also like

Psychedelic Firm Sued for Trade Secret Theft

3 Feb • 4 reads

article image

Amanita Muscaria: Deadly Fad Masquerading as Health Aid

27 Jan • 33 reads

article image

Pink Cocaine: Deadly Club Drug's True Identity Revealed

11 Jan • 158 reads

article image

AbbVie Eyes Revolution Medicines in Cancer Deal

8 Jan • 186 reads

article image

Xeris Stock Soars on Rival Drug Rejection

2 Jan • 175 reads

article image